The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.

Sahin, Orhan; Aktoz, Fatih; Bagci, Helin; Vurgun, Eren

Sahin, Orhan; Aktoz, Fatih; Bagci, Helin; Vurgun, Eren.

Afiliação

Sahin O; Department of Obstetrics and Gynecology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.
Aktoz F; Department of Obstetrics and Gynecology, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Bagci H; Department of Obstetrics and Gynecology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.
Vurgun E; Department of Medical Biochemistry, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.

J Obstet Gynaecol ; 42(6): 1917-1921, 2022 Aug.

Article em En | MEDLINE | ID: mdl-35603633

Assuntos

COVID-19; Aspartato Aminotransferases; Biomarcadores; Proteína C-Reativa/metabolismo; COVID-19/diagnóstico; Feminino; Ferritinas; Humanos; Gravidez; Estudos Retrospectivos; SARS-CoV-2

Palavras-chave

C-reactive protein; COVID-19; ferritin; neutrophil lymphocyte ratio; pregnancy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Obstet Gynaecol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google